Shaun Rowark

Scientific Adviser
National Institute for Health and Care Excellence, United Kingdom

I do not have any relevant financial / non-financial relationships with any proprietary interests.

Presentation(s):

• Using Real-world Data to Assess Comparative Effectiveness and Safety of Apixaban and Rivaroxaban in Patients with Nonvalvular Atrial Fibrillation in the UK

  Saturday, August 27, 2022
  1:30 PM – 1:45 PM CEST